Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Amarin Pharmaceuticals Ireland Limited
Amarin Pharmaceuticals Ireland Limited_20131212
  

Amarin Pharmaceuticals Ireland Limited patents

Recent patent applications related to Amarin Pharmaceuticals Ireland Limited. Amarin Pharmaceuticals Ireland Limited is listed as an Agent/Assignee. Note: Amarin Pharmaceuticals Ireland Limited may have other listings under different names/spellings. We're not affiliated with Amarin Pharmaceuticals Ireland Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amarin Pharmaceuticals Ireland Limited-related inventors




Date Amarin Pharmaceuticals Ireland Limited patents (updated weekly) - BOOKMARK this page
11/23/17Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
09/14/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
09/14/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
09/14/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
06/01/17Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
05/25/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
05/25/17Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereof
05/25/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
05/18/17Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
05/11/17Stable pharmaceutical composition and methods of using same
05/11/17Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
05/11/17Compositions and methods for treating and/or preventing cardiovascular disease
05/04/17Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
05/04/17Methods of treating hypertriglyceridemia
05/04/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
04/13/17Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
03/30/17Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
03/02/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
02/09/17Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
01/19/17Methods of treating mixed dyslipidemia
10/06/16Compositions and methods for lowering triglycerides
08/04/16Compositions and methods for lowering triglycerides
07/28/16Stable pharmaceutical composition and methods of using same
05/26/16Compositions and methods for treating or preventing obesity in a subject in need thereof
05/05/16Methods of reducing apolipoprotein c-iii
03/03/16Methods of treating hypertriglyceridemia
12/17/15Methods of reducing rlp-c
11/26/15Compositions and methods for treating and/or preventing cardiovascular disease
10/01/15Pharmaceutical compositions comprising omega-3 fatty acids
09/24/15Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
09/24/15Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
09/17/15Methods of increasing epa blood levels
09/10/15Methods of treating hypercholesterolemia
09/10/15Methods for treating hypertriglyceridemia
08/27/15Stable pharmaceutical composition and methods of using same
08/20/15Methods of treating mixed dyslipidemia
08/06/15Methods of reducing apolipoprotein c-iii
07/09/15Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
06/18/15Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
06/11/15Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
06/11/15Methods of reducing ldl-p
03/12/15Co-administration of omeprazole and eicosapentaenoic acid or a derivative thereof
03/05/15Methods of treating or preventing prostate cancer
02/19/15Methods of treating a cardiovascular disorder and/or joint pain in a subject on glucosamine therapy
02/12/15Methods of treating a cardiovascular disorder in a subject on apo-c3 modulating therapy
09/18/14Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
09/18/14Compositions comprising eicosapentaenoic acid and krill oil and methods of use thereof
09/18/14Methods of treating traumatic brain injury
09/18/14Compositions and methods for treating or preventing obesity in a subject in need thereof
09/11/14Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
09/04/14Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof
09/04/14Co-administration of warfarin and ethyl eicosapentaenoate
09/04/14Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereof
09/04/14Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acids
08/28/14Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
08/21/14Stable pharmaceutical composition and methods of using same
08/07/14Compositions comprising eicosapentaenoic acid and diazoxide and methods of use thereof
08/07/14Compositions comprising eicosapentaenoic acid and 5-htp and methods of use thereof
08/07/14Methods of reducing apolipoprotein c-iii
08/07/14Compositions and methods for treating and/or preventing cardiovascular disease
07/31/14Methods of increasing epa blood levels
07/03/14Compositions comprising epa and obeticholic acid and methods of use thereof
07/03/14Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
06/05/14Pharmaceutical compositions comprising fatty acids
06/05/14Hand wash compositions
Patent Packs
06/05/14Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
05/08/14Compositions and methods for treating and/or preventing cardiovascular disease
05/08/14Production and purification of esters of polyunsaturated fatty acids
03/27/14Stable pharmaceutical composition and methods of using same
03/20/14Stable pharmaceutical composition and methods of using same
03/13/14Highly purified ethyl epa and other epa derivatives
01/16/14Stable pharmaceutical composition and methods of using same
12/12/13Methods of treating hypertriglyceridemia
09/26/13Stable pharmaceutical composition and methods of using same
09/26/13Stable pharmaceutical composition and methods of using same
09/26/13Methods of treating mixed dyslipidemia
09/26/13Methods of treating mixed dyslipidemia
08/01/13Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
07/25/13Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
07/04/13Methods of treating hypertriglyceridemia
Patent Packs
07/04/13Methods of treating hypertriglyceridemia
07/04/13Stable pharmaceutical composition and methods of using same
07/04/13Stable pharmaceutical composition and methods of using same
06/27/13Methods of treating hypertriglyceridemia
06/27/13Stable pharmaceutical composition and methods of using same
06/20/13Stable pharmaceutical composition and methods of using same
06/20/13Stable pharmaceutical composition and methods of using same
05/23/13Pharmaceutical formulation of apomorphine for buccal administration
05/23/13Methods of treating hypertriglyceridemia
04/25/13Methods of treating hypertriglyceridemia
04/18/13Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
04/18/13Methods of treating hypertriglyceridemia
04/11/13Stable pharmaceutical composition and methods of using same
03/28/13Stable pharmaceutical composition and methods of using same
03/28/13Method for preventing or treating a disease, disorder or condition induced by retina ischemia
01/17/13Methods of treating hypertriglyceridemia
01/10/13Stable pharmaceutical composition and methods of using same
01/10/13Stable pharmaceutical composition and methods of using same
01/03/13Methods of treating hypertriglyceridemia
01/03/13Methods of treating hypertriglyceridemia
01/03/13Methods of treating hypertriglyceridemia
01/03/13Stable pharmaceutical composition and methods of using same
01/03/13Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
01/03/13Methods of treating hypertriglyceridemia
09/20/12Methods of treating hypertriglyceridemia
09/06/12Stable pharmaceutical composition and methods of using same
08/02/12Highly purified ethyl epa and other epa derivatives
12/12/13Methods of treating hypertriglyceridemia







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amarin Pharmaceuticals Ireland Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amarin Pharmaceuticals Ireland Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';